Posted 19th January 2018 by Laura Berry
The human microbiome is an area of life sciences that is gaining traction in the venture capital community. According to the Wall Street Journal, venture capital investment in microbiome companies rose 458.5 percent to 114.5 million U.S. dollars during the period from 2011 – 2015.
Posted 15th January 2018 by Laura Berry
The effects of lifestyle interventions as a baseline therapy for the treatment of NASH are well accepted. However, there is a high degree of frustration when it comes to recommending and implementing lifestyle changes. Large interventional studies in the field of metabolic disease are largely negative with regards to long-term outcomes.
Posted 12th January 2018 by Jane Williams
Intellectual Property (IP) has always been a key building block for successful healthcare businesses. However, as blockbuster patents on small molecules are becoming a thing of the past, IP in healthcare will need to evolve to meet the challenges of tomorrow. This is particularly important when considering the opportunities and challenges presented by the digital revolution, often referred to as Industry 4.0.
Posted 11th January 2018 by Gaspar Taroncher-Oldenburg
Microbiome-based interventions, whether therapeutic or prophylactic, come in a broad spectrum of modalities, a consequence of the complexity of and possibilities afforded by the microbiome.
Posted 10th January 2018 by Anna Gomez
Pathology is dealing with an area of diagnostics that is extremely variable. General pathologists are able to diagnose virtually any disease, but in rare or complex cases it is common practice to consult an expert.
Posted 8th January 2018 by Laura Berry
Antibody-drug conjugates (ADCs) combine the high specificity of a monoclonal antibody (mAb) for a target antigen with the highly potent cytotoxic activity of small-molecule drugs. Although the concept behind ADCs is relatively simple, the successful design and development of ADCs is a complex task. Similar to other biotherapeutics, the understanding of Pharmacokinetics (PK), Pharmacodynamics (PD), and Absorption, Distribution, Metabolism, and Excretion (ADME) properties of ADCs is critical for their successful development.
Big Data Analytics and Artificial Intelligence: 7 Design Principles to Empower Life Science Researchers
Posted 5th January 2018 by Laura Berry
Life sciences research is increasingly relying on big data analytics to drive scientific discovery. One of the contributing factors to this trend is the fact that researchers are confronted with a rapidly growing body of scientific literature and databases required to interpret experimental outcomes.